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INTRODUCTION
Mitral valve repair has been accepted as a procedure of
choice for surgically treating significant mitral regurgitation
(1-3). Currently, this procedure is widely applied to correct
mitral valve prolapse or chordae rupture due to myxomatous
degeneration (4-6), but mitral regurgitation due to rheumatic
involvement has been reported to have lower feasibility of
repair and higher rate of re-operation compared to myxo-
matous degenerative mitral regurgitation (1, 7-10). Recent
improvement of surgical technique and availability of intra-
operative transesophageal echocardiographic monitoring
have encouraged many surgeons to attempt valve repair in
rheumatic mitral regurgitation. However, not many reports
on clinical outcomes are available and most available clinical
data of repair in rheumatic pathology were based on mixed
results of patients with both mitral stenosis and regurgita-
tion; less than one-third had pure, predominant rheumatic
mitral regurgitation (11-13). In a few reports of patients
with pure rheumatic mitral regurgitation, the mean age of
the subjects was less than 30 yr (14, 15), and their conclu-
sions remain to be reconfirmed in different patient popula-
tion including higher mean age. Moreover, no use of rou-
tine preoperative echocardiographic screening, intraopera-
tive monitoring and postoperative follow-up study in the
previous studies might affect the assessment of the exact
role of reconstructive procedures for rheumatic mitral regur-
gitation in recent days. The purpose of this study was to
address if the underlying etiology of mitral regurgitation
affects the feasibility and outcomes of valve repair, and as a
method, clinical and echocardiographic follow-up data after
valve repair were compared between patients with rheumat-
ic mitral regurgitation and those with degenerative mitral
regurgitation.
MATERIALS AND METHODS
Subjects
The present study was based on our consecutive experi-
ence with mitral valve repair for the surgical correction of
significant mitral regurgitation from 1990 to 2000. Inclu-
sion criteria were (1) mitral regurgitation due to prolapse or
chordae rupture associated with myxomatous degeneration,
and (2) predominant mitral regurgitation due to rheumatic
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We compared clinical (30 24 months) and echocardiographic follow-up (22
20 months) data of 184 consecutive patients with myxomatous degenerative
mitral regurgitation (Group A) and 85 consecutive patients with rheumatic mitral
regurgitation (Group B) after repair. Selection criteria for rheumatic etiology was
predominant mitral regurgitation with valve area  2.0 cm
2 and with no signifi-
cant calcification in valvular apparatus. Repair was successful in 93% of group
A and in 92% of group B (p>0.05). There was no difference of operative mortali-
ty (1% vs 0%) and of the incidence of the second-pump valve replacement (4%
vs 5%). The 4-yr survival, 4-yr event-free survival, and 4-yr mitral regurgitation-
free survival rates in group A were 96 2%, 89 4%, and 76 5%, respectively,
which were not different from those in group B (97 2%, 93 4%, and 68 7%,
p>0.05). Independent determinants of development of at least moderate regur-
gitation in group A were no use of ring annuloplasty (hazards ratio 6.6, 95% CI
2.0 to 21.5) and new chordae formation (hazards ratio 3.5, 95% CI 1.4 to 8.7). In
group B, no use of ring annuloplasty (hazards ratio 15.3, 95% CI 3.5 to 66.7) also
was independent predictor. Valve repair is highly feasible in selected patients
with rheumatic mitral regurgitation, and clinical course is not significantly different
from that of patients with degenerative mitral regurgitation.
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Accepted : 22 January 2003involvement. Preoperative echocardiography (both transtho-
racic and transesophageal) was performed in all patients (with-
in 2 months before surgery) and prolapse or chordae rupture
was confirmed by both echocardiography and surgical obser-
vation. Patients with rheumatic mitral regurgitation select-
ed for valve repair had predominant moderate to severe regur-
gitation with mitral valve area  2.0 cm2 and with no signif-
icant calcification in valvular or subvalvular apparatus. Patients
with unfavorable echocardiographic morphology, such as sig-
nificant mitral stenosis (valve area <2.0 cm2) or subvalvular
calcification underwent valve replacement, were excluded in
this analysis. Other exclusion criteria were as follows: signif-
icant aortic valve disease with aortic valve repair or replace-
ment, previous valve repair or replacement, congenital or peri-
cardial disease, and mitral regurgitation due to ischemic heart
disease with or without ruptured papillary muscle. Associ-
ated incidental coronary artery disease was not an exclusion
criterion.
Surgical Procedure
In all patients, surgical repair was attempted and the 3
important procedures were subvalvular (chordal splitting,
shortening or new chordae formation), valvular (commis-
surotomy, resection or plication), and annular (mostly ring
insertion) interventions. Intraoperative assessment of mitral
regurgitation was based on transesophageal echocardiogra-
phy in all patients; failed valve repair was defined as persis-
tence of at least moderate mitral regurgitation. 
Follow-up
Clinical (30 24 months) and echocardiographic (22
20 months) follow-up was feasible in all patients. The clini-
cal events in this study included death, reoperation, stroke,
endocarditis, and development of at least moderate mitral
regurgitation on follow-up echocardiography. Distal regur-
gitant jet area and the radius of proximal flow convergence
using color Doppler flow mapping were used for semiquan-
titation of mitral regurgitation; at least moderate mitral re-
gurgitation was defined as distal regurgitant jet area  8
cm2 or the radius of proximal flow convergence >0.5 cm at
the aliasing velocity of 40 cm/sec.
Statistical Analysis
Numerical variables were expressed as mean SD. Group
comparisons were performed with standard Student t test or
chi-square test as appropriate. The Kaplan-Meier method
was used to estimate the cumulative probability of survival,
clinical event-free survival, and mitral regurgitation-free
survival; the 2-tailed log-rank test was used to compare the
difference between groups. Multivariate analysis to determine
the factors associated with development of at least moderate
mitral regurgitation after repair in each disease entity was
performed by using the Cox proportional hazards method,
and the initial candidate independent variables were age,
sex, New York Heart Association functional class, rhythm,
site and numbers of mitral valve segments with prolapse or
chordae rupture, preoperative left ventricular dimensions,
preoperative left ventricular ejection fraction, and surgical
procedures. A value of p<0.05 was considered statistically
significant.
RESULTS
Baseline Characteristics
During the study period, mitral valve surgery was done
in 642 patients; among them, repair was attempted in total
of 269 patients with moderate to severe mitral regurgitation
due to myxomatous degeneration (184 patients, 68%) or
rheumatic involvement (85 patients, 32%). In degenerative
mitral regurgitation group, 61 patients showed prolapse or
chordae rupture in the anterior leaflet, and 82 (45%) in the
posterior leaflet; 41 patients showed degenerative changes in
both leaflets. Table 1 summarizes the overall baseline char-
acteristics. The mean age and the prevalence rates of male
gender and hypertension were higher in degenerative mitral
regurgitation group, whereas the prevalence rate of atrial
fibrillation was higher in rheumatic mitral regurgitation
group. Ring annuloplasty was the most commonly performed
surgical procedure regardless of the underlying etiology of
mitral regurgitation. In degenerative mitral regurgitation
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No. of patients 184 85
Preoperative characteristics
Age* (yr) 52 14 39 14
Male/female* 104/80 15/70
NYHA class III-IV 91 (50%) 34 (40%)
Hypertension* 47 (26%) 1 (1%)
Atrial fibrillation* 63 (34%) 38 (45%)
LVIDS, mm*                                       41 84 4 6
EF, % 63 10 60 9
Surgical procedures
Ring annuloplasty 169 (92%) 74 (87%)
Commissurotomy* 7 (4%) 46 (54%)
New chordae formation* 117 (64%) 25 (29%)
Leaflet mobilization* 1 (0.5%) 59 (69%)
CABG* 14 (8%) 1 (1%)
Maze operation* 23 (13%) 21 (25%)
Pump time, min                             132 45                    129 53
Clamp time, min 95 36 91 44
Degenerative MR  Rheumatic MR
*p<0.05, MR; mitral regurgitation, NYHA; New York Heart Association,
LVIDs; systolic left ventricular internal dimension, EF; ejection fraction,
CABG; coronary artery bypass graft.
Table 1. Baseline characteristics of the subjectsgroup, new chordae formation (117/184, 64%) and quadr-
angular resection of the posterior leaflet (78/184, 42%) were
also frequently performed. Leaflet mobilization (59/85, 69%)
and commissurotomy (46/85, 54%) were frequently per-
formed in rheumatic mitral regurgitation group. Coronary
artery bypass graft (CABG) was more frequently done in
degenerative mitral regurgitation group, whereas maze opera-
tion in rheumatic mitral regurgitation group; however, there
was no significant difference of pump and aortic clamp time
between 2 groups.
Surgical Outcomes and Follow-up Results
The comparison of the surgical outcomes and the follow-
up results between 2 groups were summarized in Table 2.
Immediately after repair, 12 patients in degenerative mitral
regurgitation group revealed moderate regurgitation on intra-
operative transesophageal echocardiography; in rheumatic
mitral regurgitation group, 2 patients showed significant
stenosis (mitral valve area <2.0 cm2), while moderate regur-
gitation was confirmed in 5 patients. Except these patients,
repair was successful in 93% of degenerative mitral regurgi-
tation group and in 92% of rheumatic mitral regurgitation
group (p>0.05). There was no statistically significant differ-
ence of operative mortality (1% vs 0%), and of the incidence
of the second-pump valve replacement (4% vs 5%).  
During the follow-up, 2 patients in each group died and
the incidence of reoperation was not different between 2
groups (1% vs 4%, p>0.05). Stroke developed in 7 patients
of degenerative group, which is probably related with asso-
ciated hypertension. Postoperative echocardiography was
performed in all patients at 6 month intervals with the longest
follow-up duration of 22 20 months after repair. In degener-
ative mitral regurgitation group, 159 patients (86%) showed
excellent post-repair status without significant mitral stenosis
or regurgitation, and 66 patients (78%) of rheumatic group
also showed excellent results. Development of at least mod-
erate mitral regurgitation was confirmed in 13 patients (7%)
of degenerative mitral regurgitation group and in 10 patients
(12%) of rheumatic mitral regurgitation group (p>0.05).
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Surgical outcomes
Successful repair 172 (93%) 78 (92%) NS
Mitral valve replacement 7 (4%) 4 (5%) NS
Operative mortality 2 (1%) 0 (0%) NS
Clinical follow-up
Follow-up duration, months 28 73 4 12 NS
Death 2 (1%) 2 (2%) NS
Reoperation  2 (1%) 3 (4%) NS
Stroke  7 (4%) 0 (0%) NS
Echocardiographic follow-up 
At least moderate MR 13 (7%) 10 (12%) NS
Newly developed MS 2 (1%) 2 (2%) NS
4-yr survival rate 96 2% 97 2% NS
4-yr event-free survival rate 89 4% 93 4% NS
4-yr MR-free survival rate 76 5% 68 7% NS
Degenerative MR  Rheumatic MR p
MR; mitral regurgitation, MS; mitral valve area <2.0 cm
2, NS; not signifi-
cant.
Table 2. Comparison of surgical outcomes and follow-up re-
sults between degenerative and rheumatic mitral regurgitation
Fig. 1. Comparison of survival and event-free survival rates between patients with rheumatic mitral regurgitation (MR) and those with myx-
omatous degenerative MR. Numbers at bottom of each group indicate number of patients at risk for the interval.
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85 66 44 27 20The 4-yr survival, 4-yr event-free survival, and 4-yr mitral
regurgitation-free survival rates in degenerative mitral regur-
gitation group were 96 2%, 89 4%, and 76 5%, res-
pectively, and the rates were not significantly different from
those in rheumatic mitral regurgitation group (97 2%,
93 4%, and 68 7%, p>0.05, Fig. 1, 2). In multivariate
analysis, independent determinants of development of at
least moderate regurgitation in degenerative mitral regurgi-
tation group were no use of ring annuloplasty (hazards ratio
6.6, 95% CI 2.0 to 21.5) and new chordae formation (haz-
ards ratio 3.5, 95% CI 1.4 to 8.7). In rheumatic mitral regur-
gitation group, no use of ring annuloplasty (hazards ratio
15.3, 95% CI 3.5 to 66.7) was also independent predictor. 
DISCUSSION
We have proven that valve repair is highly feasible in
selected patients with predominant mitral regurgitation of
rheumatic etiology, and clinical course after repair surgery is
not significantly different from that of patients with degen-
erative mitral regurgitation. Patient selection based on the
preoperative echocardiography and the use of specific surgi-
cal procedures to repair the individual components contribut-
ing to the development of mitral regurgitation might explain
the favorable results of this study.  
Despite relatively early attempt of valve repair in rheumatic
mitral regurgitation, higher rates of failure and late re-oper-
ation compared to the degenerative mitral regurgitation
group made most physicians and surgeons believe that eti-
ology plays an important role in the results of repair (9, 10,
14, 16). Unlike the previous clinical reports, our study shows
different results of valve repair for rheumatic mitral regurgi-
tation. The subjects in the most previous reports were the
patients with mixed disease; those with predominant mitral
regurgitation comprised of less than 50% of the total patients
(11-13). It is well known that the repair for mixed rheumatic
lesions does not give gratifying results because these valves
frequently become stenotic a few years postoperatively (17).
The higher mean age of the patients with predominant
rheumatic mitral regurgitation in our study (39 14 yr)
needs to be re-emphasized. In a few studies on predominant
rheumatic mitral regurgitation, the mean age of the sub-
jects was between 11 to 27 yr (14, 15, 18). Duran and other
investigators reported that young age with high chance of
active rheumatic carditis is an important predisposing fac-
tor of re-operation (7, 8, 13, 14, 16), which has been chal-
lenged recently by another group (18). The most important
difference, we believe, is that all patients underwent preop-
erative echocardiographic screening for feasibility of repair
surgery in our study. Patients with unfavorable morphology,
such as significant stenosis (valve area <2.0 cm2) or subvalvu-
lar calcification, underwent a straight valve replacement, and,
during the study period, about 80% of the total patients with
significant rheumatic mitral regurgitation were selected for
repair after the echocardiographic screening. This may explain
the relatively higher rate of successful repair of rheumatic
mitral regurgitation in our study (92%) compared to 67%
reported by others (19).
Another interesting finding in this study is that recent
improvements of surgical techniques with understanding of
the mechanisms of mitral regurgitation contributed to the
better postoperative results. Specifically in patients with
degenerative mitral regurgitation, new chordae formation
has been accepted as a prerequisite procedure to repair pro-
lapse or chordae rupture of anterior or both leaflets (20-22),
which lesions were once regarded as a poor candidate for
repair. The findings that no use of new chordae formation
and ring annuloplasty are important determinants of pro-
gressive mitral regurgitation after repair reinforce that use
of multiple surgical interventions to repair the individual
mechanisms of mitral regurgitation in 3 different levels (sub-
valvular, valvular and annular) are necessary not only for suc-
cessful repair but also for long-term durability.
The mean clinical and echocardiographic follow-up dura-
tion of less than 3 yr is a main limitation of our study, as
development of significant mitral regurgitation and re-oper-
ation after repair increase with longer follow-up. Long-term
follow-up results are necessary to prove the durability of mitral
valve repair in rheumatic mitral regurgitation and to answer
the question if valve repair should be the favored approach
for all patients with rheumatic mitral regurgitation using
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Fig. 2. Comparison of development rate of at least moderate
mitral regurgitation (MR) on follow-up echocardiography after
repair surgery. Numbers at bottom of each group indicate num-
ber of patients at risk for the interval.
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85 57 37 20 14echocardiographic screening (23).
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